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ABSTRACT
Salmonella typhimurium is a leading cause of infectious human gastroenteritis and
systemic disease when it escapes into the bloodstream. The human serum complement
system is central in fighting systemic bacterial infections. S. typhimurium exhibits resistance
to killing by complement (serum-resistance), a trait conferred by several known virulence
genes. This study investigates a potential chromosomal complement-resistance gene in S.
typhimurium tagged by TnphoA insertional transposon mutagenesis. S. typhimurium strain
EM876 has a chromosomal TnphoA insertion and reduced serum-resistance. Inverse PCR
and subsequent DNA sequence analysis reveal the insertion to be in the gene glpQ. glpQ
codes for a periplasmic glycerophosphodiester phosphodiesterase involved in glycerol
degradation. Complementation assays using a clone of glpQ on a multicopy plasmid are
consistent with a role for glpQ in serum-resistance. glpQ is preferentially expressed at 37°C
versus 30°C. This is similar to traT and suggests that multiple temperature-regulated genes
may contribute to serum-resistance in S. typhimurium.
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INTRODUCTION
Function of complement as an immune defense
Human serum contains various proteins, the main purpose of which is to eliminate
bacteria. The most important serum proteins in this regard are those of the complement
system, a central element of the innate immune response in humans. The complement system
is composed of a complex network of soluble serum proteins which, when activated, interact
to kill microbes (26). Complement can be activated via three separate pathways: the classical
(CCP), lectin (LCP), and alternative complement pathways (ACP) (26). Different early
complement proteins are produced by each pathway, but the three pathways converge into
one when the protein C3 is cleaved into C3a and C3b (26). C3a remains unbound in serum
and acts as a chemokine for immune system mediators of inflammation. C3b opsonizes both
gram-negative and gram-positive bacteria, binding to bacterial cell surfaces to mark them for
phagocytosis. It also cleaves the next molecule in the cascade, C5, into C5a and C5b. C5b
leads to the activation of C6, C7, C8, and many C9 molecules that form a complex, which
inserts into the cell membranes of gram-negative bacteria. This complex forms a pore called
the Membrane Attack Complex (MAC). MAC kills the bacterial cell by depolarizing the cell
membrane (40).
The complement system cannot function properly as part of innate immunity without
regulation. Both membrane-bound and soluble regulatory proteins work to prevent host
tissues from becoming damaged by complement attack (26). Factor H is a soluble regulator
that prevents inappropriate activation of the ACP. C4bp is another soluble regulator that
binds to the early complement protein C4b and prevents it from initiating the cleavage of C3
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into C3a and C3b (6). Binding of C4bp to C4b inhibits activation of the CCP and LCP.
Bound regulators include a protein called CD59, which hinders assembly of the MAC (26).
Bacterial evasion of complement
Complement evasion is the major determinant of serum-resistance, since the
bactericidal action of serum for gram-negative bacteria such as S. typhimurium is due mostly
to the action of complement (42). Bacteria have a number of different mechanisms by which
they can avoid opsonophagocytosis or lysis by complement. The lipopolysaccharide (LPS) of
gram-negative bacteria contains O-antigen chains that can physically prevent components of
complement from accessing the bacterial cell surface (8). Bacteria that are coated with sialic
acids, like the host, can prevent activation of the ACP through binding of complement
regulatory proteins (40).
The capsules of both gram-negative and gram-positive bacteria can prevent
opsonization. C3b gets buried too deep in the capsule and cannot be detected by the receptors
on phagocytic cells. Similarly, gram-positive bacteria are not lysed by complement because
their thick cell walls prevent the MAC from reaching the bacterial cell membrane (40).
Genes associated with complement-resistance in Salmonella
Salmonella typhimurium is a facultative intracellular pathogen. It is a major causative
agent of food-borne gastroenteritis in humans and a severe typhoid-like systemic infection in
mice. Salmonella preferentially lives and reproduces within macrophages in a specialized
compartment called the Salmonella-containing vesicle. When Salmonella is released from the
macrophage, however, it can survive and replicate in the bloodstream (39). The presence of
bacteria in the bloodstream, bacteremia, distributes Salmonella throughout the body,
initiating a systemic infection that can be quite severe, especially in immunocompromised
2

individuals. Resistance to complement is essential to the extracellular survival and
dissemination of Salmonella. A number of different genes have been identified that play a
role in serum-resistance.
rck is a gene on the virulence plasmid of S. typhimurium that encodes the outer
membrane protein Rck. Rck prevents C9 from polymerizing correctly, and the MAC cannot
form as a result (19-21). Ail is an outer membrane protein of Yersinia enterocolitica that is
homologous to Rck and it has been shown by Biedzka-Sarek et al. (3) to bind the regulator of
the ACP, Factor H. Ail has also been shown to bind C4bp, which regulates both the CCP
and LCP (25). The homology between Ail and Rck suggests that Rck may have a similar
ability to use host complement regulators as shields against complement attack.
rsk is a small (66 bp long) region of the S. typhimurium virulence plasmid that was
found to restore serum-resistance to strains made serum-sensitive due to chromosomal
integration of the virulence plasmid. This region is too small to encode a protein, but
VandenBosch et al. (43) suggest that it may be a regulatory protein-binding site or enable
some other mechanism of interfering with complement regulators, enhancing bacterial
survival in serum.
wzzST and wzzfepE are both chromosomal genes that regulate the length of LPS
components: long O-antigen polysaccharides (L-Oag) with 16-35 O-antigen repeat units and
very long O-antigen polysaccharides (VL-Oag) with more than 100 O-antigen repeat units,
respectively. L-Oag and VL-Oag work in concert to prevent activation of the CCP by
concealing the antigenic Lipid A domain of the LPS (33). They also physically prevent
complement from reaching the bacterial cell membrane (8).
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The gene traT, located on the virulence plasmid of S. typhimurium and a conjugative
plasmid of Escherichia coli, is also responsible for serum-resistance. The primary role of
TraT is to prevent conjugative transfer of genetic material. However, cells containing the
traT gene are also protected from complement-mediated killing (41). Pramoonjago et al. (35)
showed that the traT encoded cell wall protein, TraT, prevents C5b6 complex formation and
assembly of the MAC on the surface of bacterial cells.
pagC is a chromosomal gene that encodes for the outer membrane protein PagC in
Salmonella choleraesuis and S. typhimurium. PagC belongs to a family of outer membrane
proteins that includes Rck in S. typhimurium and Ail in Yersinia enterocolitica. While it
shows a high level of amino acid sequence homology with Rck, the mechanism by which it
promotes serum-resistance remains unclear (34).
PgtE is a chromosomally encoded surface protease that cleaves complement proteins
C3b, C4b, and C5 (38). When Salmonella is still contained within macrophages, changes in
the structure of LPS result in a decrease in the amount and length of O-antigen chains (39).
Shortened O-antigen chains make the cell wall accessible to complement components
including the MAC in the extracellular environment. Ramu et al. (39) proposed S.
typhimurium uses the PgtE protease as an alternative mechanism of complement evasion
when it is released from macrophages.
Investigation of thermoregulated serum-resistance genes
In previous work conducted by this laboratory, TnphoA mutagenesis was employed to
identify temperature-dependent genes encoding serum-resistance in S. typhimurium (46).
Like many genes that encode virulence traits (30), serum-resistance appears to be
temperature-regulated in S. typhimurium (46). Virulence is also highly associated with
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exported proteins and, therefore, TnphoA is more likely to create functional insertions in
virulence genes than other types of genes (30). TnphoA is a transposable element that can
form gene fusions, providing a way to identify proteins (and the genes encoding these
proteins) that are exported from the cytoplasm of the cell. The 5’ end of the phoA gene is
truncated to remove its signal sequence. Alkaline phosphatase (PhoA) can only be expressed
if TnphoA inserts into the coding sequence of a gene for an exported protein, downstream of
the gene’s own native promoter and signal sequence, and in-frame with translation (24, 31).
Since it was found that S. typhimurium is more resistant to complement at 37°C than at 30°C,
more than 500 TnphoA insertion mutants were screened for temperature-regulated genes
exhibiting increased sensitivity to human serum. The screen was carried out by growing
isolates at both 37°C and 30°C and measuring the PhoA activity for each isolate at both
growth temperatures. Four mutants were found that had increased PhoA expression at 37°C,
had decreased survival in serum, and had no reduction in growth rate in decomplemented
serum. Three of them had mutations that mapped to the traT gene located on the 95 kb
virulence plasmid (46). The fourth (EM876) had a mutation that mapped to the chromosome,
but was not further investigated at that time.
The purpose of the current study is to identify the chromosomal gene disrupted by
TnphoA that we predict to function in serum-resistance. If the TnphoA insertional mutation in
strain EM876 is indeed responsible for the temperature-sensitive phenotype, then addition of
a normal gene to the mutant strain will restore serum-resistance. Therefore, this study
identified the site of the insertion, cloned the wild-type gene, and tested for the ability of the
cloned wild-type gene to complement the mutant.
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MATERIALS AND METHODS
Bacterial Strains and Plasmids
All strains of S. typhimurium and E. coli used in this study are listed in Table 1.
CR6600 is a virulent human isolate and CR8500 is a virulent avian isolate of a different
biotype than CR6600. Both of these wild-type strains have been described previously (23). E.
coli strain DH5αλpir and S. typhimurium strain JS198 were obtained from James Slauch
(University of Illinois, Urbana-Champaign), and both express the Pi protein necessary for
conditional replication of the lambda Red vectors. Strains EM1261 – EM1300 were
generated during the course of the current study. All plasmids used in this study are listed in
Table 2. Plasmids pKD3, pKD46, and pCP20, were obtained from James Slauch. Primer
DNA sequences are listed in Table 3.
Table 1. List of Bacterial Strains Used in This Study
Strain

Species

Description

Source/Reference

CR6600

S. typhimurium

TML wild-type (human isolate)

(23)

CR8500

S. typhimurium

S850 FIRN wild-type (avian isolate)

(23)

CR7020

S. typhimurium

S850 StrR

(44)

LB5010

S. typhimurium

hsdLT (r-m+), hsdSA (r-m+), hsdSB (r-m+),
metA22, metE551, trpD2, leu, val, rpsL120,
galE

(10)

EM876

S. typhimurium

glpQ::TnphoA fusion

(46)

EM518

S. typhimurium

EM876 and EM1830 parent strain

(46)

EM1830

S. typhimurium

TnphoA fusion in an unidentified gene

(46)

EM1235

S. typhimurium

EM876/pLX9610

DH5αλpir

E. coli

endA1, hsdR17, supE44, thi-1, recA1, gyrA,
relA1, DEL(lac-argF)U169, deoR ϕ80,
6

this study
(15)

Δ(lac)M15, λ pir+ / pKD3
JM109

E. coli

endA1, recA1, gyrA96, thi, hsdR17 (rk–,
mk+), relA1, supE44, Δ( lac-proAB), [F´
traD36, proAB, laqIqZΔM15]

Promega

JS198

S. typhimurium

LT2, metE55,1 metA2,2 ilv452, trpB2,
hisC527(am), galE496, xyl-404, rpsL120,
flaA66, hsdL6, hsdSA29, zjg8103::pir+
recA1

(15)

EM1261

S. typhimurium

JS198/pKD46

this study

EM1270

S. typhimurium

S850/pKD46

this study

EM1271

S. typhimurium

TML/pKD46

this study

EM1282

S. typhimurium

JS198 ΔglpQ::cat

this study

EM1287

S. typhimurium

S850 ΔglpQ::cat (a). P22 transductant from
EM1282

this study

EM1289

S. typhimurium

S850 ΔglpQ::cat (c). P22 transductant from
EM1282

this study

EM1290

S. typhimurium

TML ΔglpQ::cat (d). P22 transductant from
EM1282

this study

EM1292

S. typhimurium

TML ΔglpQ::cat (f). P22 transductant from
EM1282

this study

EM1293

S. typhimurium

S850 ΔglpQ (a)

this study

EM1294

S. typhimurium

S850 ΔglpQ (c)

this study

EM1295

S. typhimurium

TML ΔglpQ (d)

this study

EM1296

S. typhimurium

TML ΔglpQ (f)

this study

EM1297

S. typhimurium

S850 ΔglpQ (a)/pLX9610

this study

EM1298

S. typhimurium

S850 ΔglpQ (c)/pLX9610

this study

EM1299

S. typhimurium

TML ΔglpQ (d)/pLX9610

this study

EM1300

S. typhimurium

TML ΔglpQ (f)/pLX9610

this study
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Table 2. List of Plasmids Used in This Study
Plasmid

Description

Source/Reference

pGEM-T Easy

TA cloning and sequencing vector

Promega

pAM1110

pGEM-T Easy::Mogull inverse PCR product

this study

pBB2208

pGEM-T Easy::Rahme inverse PCR product

this study

pBH2011

pGEM-T Easy::Purdy inverse PCR product

this study

pLX9610

pGEM-T Easy::glpTQ

this study

pKD3

Pi-dependent lambda Red template plasmid, with
FRT flanked cat cassette

(14)

pKD46

Red recombinase expression plasmid

(14)

pCP20

Flippase (FLP) helper plasmid

(13)
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Table 3. Primer Sequences Used in This Study
Primer

Sequence (5’-3’)

Source

Mogull 1

CAAAACGGGAAAGGTTCCG

(32)

Mogull 2

GCTCTGCGTGATTCTCTTAGCG

(32)

Rahme 1

AATATCGCCCTGAGCAGC

(37)

Rahme 2

AATACACTCACTATGCGCTG

(37)

Purdy 1

ATATCGCCCTGAGCAG

(36)

Purdy 2

CAACCGGTGTCAAAACC

(36)

glpTQ
forward

GGTATCGCCTTATTGCCAGA

this study

glpTQ
reverse

AATGTTTGATTTCGCGCATA

this study

glpQ H1P1

TGAGGCGTTTATGCCCTCATCCGGCGCGTCACTTCGACTATGGCAAACCTTGTAGGCTGGAGCTGCTTCG

this study

glpQ H2P2

AAAACGCCATCATGATGAGCTGCAGTTAAAACGCAACGGAGGCTAATAACCATATGAATATCCTCCTTAG

this study

c1

TTATACGCAAGGCGACAAGG

(14)

c2

GATCTTCCGTCACAGGTAGG

(14)

glpQ ko
forward

CCGGCGCGTCACTTCGACTAT

this study

glpQ ko
reverse

GCTGCAGTTAAAACGCAACGGAG

this study

glpQ int
forward

TTCCGCCACCTGCTTCATAG

this study

glpQ int
reverse

CTGATTTCCGCATTCATACCTTTG

this study
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Culture Conditions
Luria-Bertani (LB) broth and agar plates (Acumedia, Neogen Corporation, Lansing,
MI) were used for routine growth and maintenance of S. typhimurium and E. coli strains at
37°C, unless otherwise indicated. The following antibiotics were used as appropriate:
streptomycin, 500 µg/ml; kanamycin, 50 µg/ml; ampicillin, 100 µg/ml; chloramphenicol, 30
µg/ml.
Chemicals, Enzymes, and Reagents
Antibiotics and p-nitrophenyl phosphate (pNPP) substrate were purchased from
Sigma (St. Louis, MO). Isopropyl-beta-D-thiogalactopyranoside (IPTG) and 5-bromo-4chloro-3-indolyl-beta-D-galactopyranoside (X-gal) were purchased from Gold Biotechnology
(St. Louis, MO). L-arabinose was obtained from EMD Chemicals, Inc. (San Diego, CA).
Sodium dodecyl sulfate (SDS) as well as miscellaneous media additives were obtained from
Gibco BRL (Carlsbad, CA). GelRed DNA stain was purchased from Biotium, Inc. (Hayward,
CA). Restriction enzymes and Taq polymerase were purchased from New England BioLabs,
Inc. (NEB; Ipswich, MA), unless otherwise noted.
DNA Preparation
All genomic DNA was prepared using the Qiagen DNeasy Blood & Tissue kit
(Valencia, CA). Plasmid DNA was prepared using the PureYield™ Plasmid Miniprep
System (Promega, Madison, WI). All kits were used according to manufacturer’s directions.
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Other Genetic/Molecular Methods
PCR - PCR primers in this study were designed using the program Primer 3
(http://primer3.sourceforge.net/) and synthesized by Integrated DNA Technologies, Inc.
(Coralville, IA).
Competent Cell Preparation – Electrocompetent cell preparation was adapted from
the method described by Maloy et al. (30). Overnight cultures were diluted 1:100 in fresh
Super Optimal Broth (SOB) medium (18) and incubated at 37°C with aeration until they
reached mid to late log phase (OD600 = 0.6 – 0.8). Cultures were transferred to 50 ml conical
tubes, cooled on ice for 15 minutes, then centrifuged at 2450 x g for 10 minutes at 4°C. Cells
were suspended in 0.2 volumes ice-cold sterile deionized water, then centrifuged at 2450 x g
for 10 minutes at 4°C. Cells were washed two additional times with 0.1 volumes, then 0.02
volumes ice-cold sterile deionized water. Cells then were suspended in 0.01 volumes ice-cold
10% (v/v) glycerol, transferred to 1.5 ml tubes, and centrifuged at 6000 x g for 5 minutes.
Cells were suspended one last time in 0.01 volumes ice-cold 10% glycerol, aliquoted into
chilled 1.5 ml tubes, and frozen at -80°C until ready for use.
Transformation – Chemically competent JM109 E. coli were purchased from
Promega and transformed via heat shock according to the manufacturer’s instructions.
Electrocompetent cells were transformed via electroporation using a Gene Pulser apparatus
(Bio-Rad, Hercules, CA) as follows. 40 µl cells were mixed with 1-2 µl DNA in a sterile
microcentrifuge tube on ice and then transferred to a chilled 0.2 cm electroporation cuvette.
Cells were shocked in a Gene Pulser (Bio-Rad) set at 25 µF, 200 Ω, and 2.5 kV for 4.7 msec.
Recovery was in 1 ml Super Optimal Catabolite-repression (SOC) medium (18) with aeration
(200 rpm) at 37°C for 1 hour.
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DNA Sequencing and Sequence Analysis – DNA sequencing was performed on an
Applied Biosystems 3730 XL sequencer at the University of Michigan DNA Sequencing
Core (http://seqcore.brcf.med.umich.edu/). Standard premade SP6 and T7 sequencing
primers, provided by the sequencing core, were used on mini-prep plasmid template DNA.
Nucleotide searches of the GenBank database were performed using the BLASTN
algorithm (1). MacVector 9.0 (Cary, NC) was used for ClustalW alignments, sequence
annotation, and to generate sequence graphics.
Agarose Gel Electrophoresis – Agarose gel electrophoresis was performed with either
sodium borate or lithium borate buffers as described previously (9). Gels were composed of
1% - 2% agarose with GelRed DNA stain (Biotium) added prior to melting. The 1 Kb Plus
DNA Ladder from Invitrogen (Carlsbad, CA) was used to estimate the molecular weight of
DNA fragments, however, exact DNA fragment sizes were determined from sequence data.
Blue/Orange Loading Dye, 6X (Promega) was added to DNA prior to loading samples onto
agarose gels. Gels were UV visualized and photographed using a Gel Doc™ XR+ System
(Bio-Rad).
Statistical Analysis
Statistical analyses of data were performed using the computer software program
JMP, Version 9.0.2, SAS Institute, Inc., Cary, NC, 1989-2011. One-way analysis of variance
(ANOVA) was performed with Dunnett’s multiple comparison testing against a control
group. Significance was accepted at p<0.05.
Identifying Location of TnphoA Insertion
The location of the TnphoA insertion in mutant EM876 was determined by inverse
PCR as previously described (32). In brief, chromosomal DNA was digested by the
12

restriction enzyme TaqI, which has a site located 403 bp downstream of the 5’ end of
TnphoA. The resulting DNA fragments were circularized by T4 DNA ligase. PCR was
performed using three separate sets of primers, Mogull (32), Rahme (37), and Purdy (36),
listed in Table 3. The primers are specific to TnphoA and face away from one another to
amplify the unknown sequence adjoining TnphoA. GoTaq® Green Hot Start Master Mix
(Promega) was used with 1 µM of each of the forward and reverse primers and
approximately 10 ng of TaqI-digested circularized DNA. The following PCR conditions were
used: initial 2 min incubation at 94°C, followed by 30 cycles (94°C for 1 min, 51°C for 1
min, 72°C for 1 min), with a final extension at 72°C for 5 min. The PCR products were gelpurified using Zymoclean™ Gel DNA Recovery Kit (Zymo Research, Irvine, CA) and
ligated into pGEM-T Easy to create plasmids pAM1110, pBB2208, and pBH2011 that were
transformed into E.coli strain JM109 for blue/white screening. Gel purification and ligation
into pGEM-T easy were both done according to the manufacturer’s instructions. Plasmid
DNA from each of the above-mentioned plasmids was isolated from several white colonies
and sequenced. For each plasmid, BLASTN analysis of sequence data revealed the site of the
TnphoA insertion to be the chromosomal gene, glpQ, which encodes a periplasmic
glycerophosphodiester phosphodiesterase.
Cloning of glpQ
glpQ is the promoter distal gene in the glpTQ operon. The promoter proximal gene,
glpT, encodes a glycerol-3-P permease. The entire glpTQ operon (including the native
promoter and regulatory binding sites; Figure 3) of S. typhimurium strain CR8500 was PCR
amplified using 1 unit Phusion™ High-Fidelity DNA Polymerase (NEB, Ipswich, MA), 200
ng chromosomal DNA isolated from wild-type strain CR8500, 0.2 µM of each of the primers

13

glpTQ forward and glpTQ reverse (Table 3.), 200 µM deoxyribonucleotide triphosphate
(dNTP) mixture, and 1x Phusion™ HF Buffer. PCR conditions include an initial 2 min
denaturation at 98°C, followed by 30 cycles (98°C for 10 s, 59.8°C for 30 s, 72°C for 1 min
30 s). PCR products were purified with DNA Clean & Concentrator™-5 (Zymo Research).
Deoxyadenosine triphosphates (dATPs) were added to the 3’ end of the PCR products to
allow for ligation into pGEM-T Easy. In brief, GoTaq® Green Hot Start Master Mix
(Promega) was incubated with purified PCR products as follows: denaturation at 94°C for 2
minutes, followed by extension at 72°C for 30 minutes. Once the PCR products were Atailed, they were cloned into pGEM-T Easy, creating complementation plasmid, pLX9610.
The construct was confirmed by DNA sequencing.
Construction of Recombinant Strains
glpQ deletions in S. typhimurium CR8500 and CR6600 were made using the lambda
Red system, as described by Datsenko and Wanner (14). The procedure would replace glpQ
with an antibiotic resistance cassette that has flippase recognition target (FRT) sites for easy
removal later on, as shown in Figure 6. Seventy-nucleotide primers, glpQ H1P1 and glpQ
H2P2 (Table 3), made up of 50 bp of homologous glpQ flanking sequences, H1 and H2, plus
20 bases of primer extensions, P1 and P2, were used to PCR amplify the FRT-cat cassette out
of plasmid pKD3. PCR was conducted using 1.25 units OneTaq™ Hot Start DNA
Polymerase (NEB) with 1 unit Phusion™ High-Fidelity DNA Polymerase (NEB), 1x
OneTaq Standard Reaction Buffer, 200 µM dNTP mixture, 0.2 µM of each primer, and
approximately 1.5 ng pKD3 plasmid DNA. PCR conditions were as follows: initial
denaturation at 94°C for 30 s, followed by 35 cycles (94°C for 20 s, 67°C for 40 s, 68°C for 2
min), and a final extension at 68°C for 5 min. The 1100 base pair amplicon was then purified
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and concentrated using the Wizard® SV Gel and PCR Clean-Up System (Promega)
according to product instructions.
The plasmid pKD46 is under the control of a temperature-sensitive origin of
replication, and expression of the Red recombinase genes is controlled by an arabinose
promoter. Strains harboring this plasmid must be propagated and maintained at 30°C, and
recombinase activity is only induced by adding L-arabinose to the growth medium (14).
Twenty-four ng pKD46 was transformed into 40 µl freshly prepared competent S.
typhimurium strains CR8500, CR6600, and JS198. Recovery was 1.5 hours at 30°C in 1 ml
SOC medium with aeration (200 rpm). Cultures were spread on LB ampicillin plates and
incubated overnight at 30°C. Several transformants of each strain were colony purified,
plasmid DNA was isolated, and the presence of pKD46 was verified by restriction analysis
with EcoRI. EcoRI cuts pKD46 into two fragments of 4820 and 1509 bp, respectively.
Agarose gel electrophoresis showed the expected bands in all strains tested.
Strains bearing pKD46 were made competent and Red recombinase expression was
induced with L-arabinose in the following manner. Overnight cultures, grown in SOB with
ampicillin, were diluted 1:100 into fresh SOB containing ampicillin and 100 mM Larabinose. Control (non-induced) strains were grown in the same way, except without
addition of arabinose. Cultures were incubated in a rotary shaker set at 175 rpm and 30°C for
3 hours 40 minutes until they reached mid to late log phase (OD600 = 0.6-0.8). At this point,
cultures were made competent as usual and stored at -80°C until ready for use.
824 ng of the PCR product, consisting of the amplified FRT-cat cassette with glpQ
homology extensions, was transformed into both arabinose-induced and non-induced
CR8500, CR6600, and JS198 strains containing pKD46. Transformants were recovered in
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SOC, with aeration, at 37°C for 3 hours. During the recovery process, the Red recombinase,
which was induced with arabinose earlier, promotes homologous recombination between the
homology extensions of the PCR product and the corresponding region on the chromosome.
Once recombination has taken place, glpQ is replaced by the FRT-cat cassette. After
recovery, cells were pelleted and suspended in 200 µl of fresh SOC. 100 µl were plated on
LB plates containing 10 µg/ml chloramphenicol and incubated overnight at 37°C.
Transformants were streaked onto fresh chloramphenicol plates and PCR screened for
replacement of glpQ with the FRT-cat cassette using primers designed to amplify the 5’
junction fragment, glpQ ko forward and c1 (Table 3), which produces a 247 bp fragment.
Agarose gel electrophoresis was performed on the PCR products, and several isolates of each
strain that had a band at 247 bp were chosen for further analysis. The isolates were colony
purified and re-streaked several times on plain LB plates at 42°C to eliminate plasmid
pKD46, which encodes ampicillin-resistance.
Because the Red recombinase can cause unwanted recombination events, the glpQ
deletions were moved from S. typhimurium strain EM1282 (JS198 ΔglpQ::cat) into clean
CR8500 (S850) and CR6600 (TML) backgrounds by P22 HT int transduction (30).
Transductants (EM1287, EM1289, EM1290, and EM1292) were made competent and
transformed with the temperature-sensitive plasmid, pCP20. The flippase encoded by pCP20
recognizes the FRT sites flanking the chloramphenicol marker and removes the marker. The
plasmid and the antibiotic resistance marker are simultaneously cured from the transductants
by passaging at 42°C, resulting in S850 ΔglpQ strains EM1293 and EM1294 and TML
ΔglpQ strains EM1295 and EM1296, which were now ready for complementation. The
deletion of glpQ was confirmed by PCR using primers, glpQ ko fwd and glpQ ko rev (Table
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3), designed to amplify glpQ and its flanking regions. PCR products were analyzed via gel
electrophoresis and visualization.
The above-mentioned glpQ deletion strains were made competent and complemented
by transformation of plasmid pLX9610, which carries the glpTQ operon, resulting in strains
EM1297, EM1298, EM1299, and EM1300.
Alkaline Phosphatase Assays
The temperature-dependence of glpQ gene expression was assessed by alkaline
phosphatase assays on S. typhimurium strain EM876 with the TnphoA insertion in glpQ (30).
EM876 cultures were grown overnight at both 30°C and at 37°C in L broth supplemented
with 50 µg/ml kanamycin. 1.5 ml aliquots of culture were washed once in 750 µl of
phosphate buffered saline (PBS; BD/Difco, Franklin Lakes, NJ), then suspended in an equal
volume of PBS. 200 µl cells were added to 1700 µl assay buffer, pH 10.1 (30 mM Na2CO3,
20 mM NaHCO3, 0.005% SDS, and saturated with chloroform), then 200 µl of 0.4% pNPP in
glycine buffer (0.1 M glycine, 1 mM ZnCl2, 1 mM MgCl2, pH 10.4) was added to the cell
suspension. Alkaline phosphatase production was quantified spectrophotometrically by
absorbance at 410 nm and normalized against cell density absorbance at 570 nm. Absorbance
readings were taken every 30 minutes for several hours. Normalized alkaline phosphatase
activity was determined by the following formula:
phoA Activity = (A410 – k A570) / A570
k is a proportionality constant experimentally determined by the ratio A410 / A570. In this case,
k = 1.95.

17

Alkaline phosphatase expression was determined by the ratio of phoA activity at 37°C
to phoA activity at 30°C. Higher ratios indicate that cultures grown at 37°C had more
alkaline phosphatase expression than the same cultures grown at 30°C.
Serum Killing Assays
Unless otherwise noted, pooled normal human sera (PNHS) purchased from Sigma
(catalog number S1764) were used for serum killing assays. 18-hour cultures were grown
with aeration at 37°C and diluted in either PBS or Veronal-buffered saline with 1% gelatin
(VBSG; Sigma). The diluted culture was inoculated into PNHS to a final concentration of
about 1 x 105 cfu/ml and 90% PNHS. Time 0 samples of the mixture were taken and plated
in triplicate on tryptic soy agar (TSA; Acumedia). The culture/serum mix was then incubated
at 37°C with 5% CO2 to maintain the appropriate pH. Samples were plated again at 2 hours
and 6 hours post-inoculation. Serum killing was determined by percent survival (viable
counts) at 2 hours and 6 hours compared with the initial plating at time 0. Serum sensitivity
of mutants was determined by comparing percent survival with that of the parent strains.
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RESULTS
Determination of TnphoA Insertion Site
Inverse PCR was conducted using primers described by Mogull et al., Rahme et al.,
and Purdy et al. in order to amplify the gene disrupted by TnphoA (32, 36, 37). Three primer
sets were used to increase the likelihood of isolating this gene. Each primer set produced a
DNA fragment of a different size, as shown in Figure 1. Inverse PCR involves digesting
TnphoA-containing genomic DNA with a restriction enzyme and then circularizing the
resulting DNA fragments with T4 DNA ligase. The primers are outward facing and specific
to TnphoA and should be able to amplify a stretch of unknown DNA sequence adjacent to it
since all of the DNA fragments are circularized. The restriction enzyme chosen was TaqI,
which has a cut site in TnphoA 403 bp downstream from the 5’ end of the transposon (32).

Figure 1. Inverse PCR products with TnphoA-based primers analyzed on a 1.2% agarose
gel. The 1 Kb Plus DNA ladder (Invitrogen) was used to estimate the molecular weight of
the bands. Amplicon size was determined from sequence analysis.
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Sequence Analysis of Inverse PCR Products
Once inverse PCR products were gel-purified and cloned into pGEM-T Easy
(Promega), one representative isolate from each primer set was sent out for DNA sequencing.
Sequences were compared to the GenBank database using the BLASTN algorithm and
aligned with the gene glpQ. ClustalW analysis of the inverse PCR fragments revealed the
location of the glpQ::TnphoA fusion (Figure 2). As shown in Figure 3, glpQ is the distal gene
of the glpTQ operon, with both promoter elements and binding sites for the gene regulators
CRP, GlpR, and FNR upstream of the first gene in the operon, glpT (1, 4).
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Figure 2. Detail of the 5' TnphoA junction with glpQ. The graphic of the junction
sequence shows the location of the fusion of glpQ to phoA. The underlined nucleotides
represent the signal sequence for glpQ, which is upstream of the gene fusion.
Cloning of glpQ
In order to clone glpQ for complementation, DNA primers were designed to PCR
amplify the region from approximately 200 bases upstream of glpT to 200 bases beyond the
transcriptional end of glpQ. This was done to ensure that the necessary promoter elements
and regulatory regions were also amplified along with glpQ. The resulting amplicon was
nearly 3000 bp, which is longer than the standard Taq polymerase could effectively amplify.
Therefore, PCR was done using Phusion™ polymerase (NEB), which has high processivity
as well as 3’ to 5’ proofreading ability. Phusion™ polymerase can amplify long DNA
templates, but results in blunt-ended products that are not suitable for TA-cloning because of
the lack of 3’ A-overhangs. To address this issue, dATPs were added to the 3’ ends of the
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glpTQ amplicon as described in Materials and Methods. This amplicon was TA-cloned into
pGEM-T Easy (Promega) to create the complementation plasmid, pLX9610.

Figure 3. The glpTQ operon showing the TnphoA insertion site. Map based on the
genome of S. typhimurium LT2 (GenBank Accession NC_003197.1; complement
(2387000..2392000)). The direction of glpTQ transcription is opposite that of the
surrounding genes.
Evidence for Temperature Regulation of glpQ in S. typhimurium.
EM876 was originally selected for its increased expression of phoA at 37°C
compared to 30°C. It is possible that this difference in expression could be an artifact from
the loss of GlpQ activity, perhaps due to autogenous regulation of the glpTQ operon. To test
for this possibility, alkaline phosphatase assays were performed on EM876 and the
complemented strain, EM1235. Both EM876 and EM1235 have equal, high phoA activity
ratios (Figure 4). Therefore, the loss of GlpQ activity has no effect on the temperaturedependence of glpQ expression. In comparison, strain EM1830, which has a TnphoA
insertion in an unmapped gene, has a low activity ratio, suggesting increased expression at
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30°C. Other strains with TnphoA fusions that are not temperature-regulated have ratios near
1.0 (not shown).

Figure 4. Temperature-dependent alkaline phosphatase expression in Salmonella.
Mutant strain EM876 and glpQ-complemented mutant, EM1235, have similar PhoA
expression when grown at 37°C. Control strain EM1830, conversely, has increased
expression at 30°C. Error bars represent the standard error of the mean (SEM) of four
experiments. *, p < 0.05 compared with the EM1830 control.
Serum Sensitivity of S. typhimurium Strains EM876, EM518, EM1235, and CR7020
A critical characteristic of strain EM876 is that it displays increased sensitivity to the
bactericidal effects of serum. Strain EM876 was derived from the wild-type S. typhimurium
strain S850 through a series of changes (46). In brief, a spontaneous streptomycin-resistant
mutant strain (CR7020) was selected from S850. This strain was then transduced with a
phoN mutation linked to a Tn10 insertion. PhoN is a neutral phosphatase that could
confound the detection of phoA insertion mutants. The phoN strain EM518 was then selected
by growth on Bochner’s medium with the spontaneous excision of the Tn10 (30). Strain
EM518 served as the parent of a large set of TnphoA insertion mutants, including EM876. If
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the increased sensitivity of EM876 is due to the loss of GlpQ activity, then it should be
reversed by complementation with the plasmid pLX9610, containing the intact glpTQ
operon. Serum killing assays were performed to confirm the increased sensitivity to normal
human serum of strain EM876, with glpQ interrupted by TnphoA, compared to EM518, the
parent of EM876, and to the S850 derivative CR7020, with the intact phoN gene. In these
assays EM876 was significantly more susceptible to serum than the parental lineage strains
EM518 and CR7020 (Figure 5). Importantly, this increased sensitivity was reversed with the
complementing plasmid in strain EM1235 (EM876/pLX9610).
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Figure 5. Serum bactericidal assay results showing decreased survival of S.
typhimurium mutant strain EM876 relative to strains CR7020 (wild-type), EM518
(EM876 parent strain), and EM1235 (EM876 complimented with glpTQ). Mutant
EM876 displays a serum-sensitive phenotype, which is reversed with addition of glpTQ
on a multicopy plasmid. Data are from a two-hour incubation in 90% PNHS. Error
bars represent the SEM of three experiments. *, p < 0.05 compared with control.
Construction of Wild-type glpQ Deletion Strains
The derivation of strain EM876 involved a long series of genetic manipulations that
could have introduced unintended mutations capable of influencing serum-resistance. In
order to confirm that the decrease in serum-resistance in EM876 was due to the disruption of
glpQ and not to some other cryptic mutation, glpQ deletions were constructed in wild-type
CR8500 and CR6600 backgrounds. Because bacteriophage P22 is unable to infect EM876,
P22 transduction could not be used to move the TnphoA insertional mutation in glpQ directly
from EM876 into the wild-type strains. This necessitated the creation of de novo glpQ
knockouts. To construct these mutations, the lambda Red system was used to remove only
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the glpQ gene from CR6600 (TML) and CR8500 (S850), while leaving everything else
upstream and downstream of glpQ intact. Figure 6 shows the genomic region of S.
typhimurium LT2 surrounding glpQ and the construction of the glpQ deletion with the
locations of all primers.
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Figure 6. Construction of a glpQ deletion in S. typhimurium LT2. (A.) The genomic
region surrounding and including the glpTQ operon. (B.) Replacement of glpQ with the
FRT-cat cassette; glpQ ko fwd/c1 and glpQ ko rev/c2 are PCR primers for the 5’- and 3’junctions, respectively; H1 and H2 refer to homologous glpQ flanking regions; P1 and
P2 are priming sites for amplification of the FRT-cat cassette; FRT is “Flippaserecognition target”, used to remove the antibiotic-resistance cassette (C.) Removal of
the antibiotic resistance cassette leaves an 83-nt FRT “scar” site, consisting of P1 and
P2 (yellow boxes) and one FRT site (orange box), in place of the deleted gene.
In order to make isogenic glpQ deletion strains of CR6600 and CR8500, the glpQ
deletion was first made in strain JS198, resulting in EM1282 (JS198 ΔglpQ::cat). JS198 is a
derivative of S. typhimurium LT2, which is sensitive to bacteriophage P22. Therefore,
EM1282 was used as the donor for P22 transduction to move the mutation in glpQ into
CR6600 and CR8500 backgrounds, creating strains EM1287 – EM1292.
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To ensure that glpQ was replaced by the FRT-cat cassette in EM1282, colony PCR
was performed with primer sets designed to amplify the 5’- and 3’- FRT-cat cassette junction
regions, as well as a glpQ internal fragment (Figure 7).

Figure 7. glpQ replacement with FRT-cat cassette in P22 donor strain EM1282 analyzed
on a 2% agarose gel. The 1 Kb Plus DNA ladder (Invitrogen) was used to estimate
molecular weight. Amplicon sizes were determined from sequence analysis.
Primer set glpQ ko forward and c1 were used to amplify the 5’ junction (Figure 6B),
giving an amplicon of 244 bp and primer set glpQ ko reverse and c2 amplified a 122 bp
fragment of the 3’ junction. Amplification only occurred if glpQ was replaced by the FRTcat cassette. As shown in Figure 7, there are no bands for JS198, which still has glpQ intact.
To be certain that EM1282 was a glpQ deletion mutant, a third primer set (glpQ internal
forward and glpQ internal reverse) amplified a 395 bp stretch of DNA near the middle of
glpQ (Figure 6A). Figure 7 shows that only JS198 still contains the glpQ gene, whereas
EM1282 shows no amplification. PCR using these primer sets was also performed on
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transductant strains EM1287 – EM1292, which demonstrated the same pattern of
amplification (not shown).

Figure 8. Identification of the FRT scar site. 2% agarose gel showing PCR amplicons of
intact glpQ gene and FRT-cat cassette excision site. Marker is the 1 Kb Plus DNA
ladder (Invitrogen).
Following P22 transduction to move the glpQ deletion into new CR8500 and CR6600
backgrounds (resulting in EM1287, EM1289, EM1290, and EM1292), plasmid pCP20,
encoding a flippase, was transformed into the transductants to remove the FRT-cat cassette.
Removal of the antibiotic resistance cassette results in a FRT scar site of 83 bp (14), which
includes the residual FRT-cat cassette (Figure 5C). PCR using primers flanking the scar site
was used to confirm the presence of this scar, which resulted in an amplicon of 145 bp
(Figure 8). The presence of either glpQ or the FRT-cat cassette results in an amplicon of
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approximately 1100 bp. Strains EM1293 – EM1296 resulted from successful removal of the
FRT-cat cassette (Figure 8).
Serum Killing Assays with ΔglpQ Strains
Serum killing assays were performed to test the serum resistance of the new glpQ
deletion mutants of CR6600 and CR8500, both alone and with the addition of glpTQ on
pLX9610. When compared with initial serum killing assays with EM876, the glpQ deletion
mutants showed decreased survival in serum relative to the wild-type strains. However, when
the glpQ deletion mutants were complemented with glpTQ on a plasmid, the level of survival
further decreased, as shown in Figure 9. For the most part, this trend persisted across
experiments and strains. The only minor exception is seen in the lower right graph in Figure
9. In this case, EM1294 (ΔglpQ) had the highest survival at 4 and 6 hours, followed by
EM1298 (ΔglpQ/pLX9610), while the wild-type CR8500 had the lowest survival at 4 and 6
hours.
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Figure 9. Effect of glpQ deletion and complementation in wild-type backgrounds. The
upper two graphs show the survival of the wild-type strain (○ CR6600), ΔglpQ strains
(□ EM1295 and □ EM1296), and ΔglpQ/pLX9610 strains (△ EM1299 and △ EM1300).
The lower two graphs show the survival of the wild-type strain (○ CR8500), ΔglpQ
strains (□ EM1293 and □ EM1294), and ΔglpQ/pLX9610 strains (△ EM1297 and △
EM1298). Error bars represent the SEM of at least three experiments; *, p<0.05; * *,
p<0.1.
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DISCUSSION
The purposes of this study were twofold: first, to identify the chromosomal gene
disrupted by the TnphoA insertion in strain EM876, and second, to investigate the possible
role the gene might play in temperature-regulated serum-resistance in S. typhimurium.
Determination of TnphoA Insertion Site
By employing an inverse PCR technique designed to amplify TnphoA insertion
junctions, cloning, and DNA sequencing of the cloned inserts, we were able to determine that
the TnphoA insertion in EM876 was in the gene glpQ, located on the chromosome. This was
an unexpected finding, as glpQ has not been previously identified as a virulence gene in
either S. typhimurium or its close relative, E.coli. Rather, glpQ is a glycerophosphodiester
phosphodiesterase (GDPD) that is located in the periplasm. Its role in the glycerol
degradation pathway is converting deacylated phospholipids to glycerol 3-phosphate and the
corresponding primary alcohol (28). These breakdown products then are transported into the
cytoplasm of the cell through the GlpT antiporter, encoded by glpT, the first gene in the
glpTQ operon. Together, the products of the glpTQ operon provide the cell with a source of
carbon and phosphate, as well as membrane lipid precursors (Figure 10) (27, 29). Although
glpQ serves primarily as a housekeeping gene, which would not be predicted to be involved
in virulence, it is being associated with virulence in some bacterial species that are not
closely related to S. typhimurium or E. coli. In Haemophilus influenzae, a glpQ-encoded
GDPD is a primary component of the virulence factor, Protein D (16). In this case, however,
GlpQ is a lipoprotein that is anchored to the outer surface of H. influenzae. It is thought that
its location outside the bacterial cell allows it to scavenge choline from host cells to use as
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LPS decoration (17). glpQ in Enterococcus faecalis has been shown to induce intermediate
resistance to class II bacteriocins by an unknown mechanism (11, 12).

Figure 10. Glycerol 3-phosphate metabolism in E. coli (taken from Larson et al. 1983).
Evidence of Temperature Regulation
There is limited evidence in Shigella flexneri to suggest that glpQ is preferentially
expressed at higher temperatures (37°C vs. 30°C) because it is under H-NS (histone-like
protein H1) regulation. Under low-temperature conditions, H-NS binding of the regulatory
region just upstream of the 5’ end of glpT represses transcription of the glpTQ operon.
However, when there is a temperature upshift, H-NS is released from its binding site and
transcription can proceed (47). Previous experiments determined that our TnphoA insertional
mutant, EM876, showed differential gene expression at 37°C vs. 30°C. When the alkaline
phosphatase assays were repeated using the glpQ-complement strain, EM1235, again there
was more phoA expression at 37°C than at 30°C. The temperature-dependent regulation of
the glpQ::TnphoA fusion in EM876 is not altered by the presence of the complementing
plasmid with the wild-type glpQ (in strain EM1235), suggesting that the temperaturedependence is not an artifact of the loss of glpQ.
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In TnphoA insertion mutants, the amount of alkaline phosphatase activity serves as a
proxy for the expression levels of the gene fused to phoA. As such, PhoA assays of EM876
and the complemented strains are an indirect measure of glpQ expression. Having a direct
measure of glpQ gene expression would be an important confirmation of the data we have
already collected. RT-PCR (reverse transcriptase PCR) is a widely accepted method of
measuring gene expression based on transcript (mRNA) levels in real time. Alternatively,
Northern blot analysis could also be used.
Serum Killing of EM876 and Controls
Serum bactericidal assays were conducted with 90% PHNS in 5% CO2 to
approximate in vivo conditions as much as possible. After two hours of incubation, EM876
had about a 30% average decrease in survival in PNHS when compared with the wild-type
(CR7020) and the parent (EM518). Previous studies (46) had demonstrated a similar 50%
reduction in survival. Complementation of EM876 with glpQ on a plasmid (EM1235)
restored serum-resistance to wild-type levels. These results suggest that the decrease in
survival of EM876 is due to the disruption of glpQ.
Construction of Wild-type glpQ Deletion Strains
EM876, its parent strain EM518, and the complementation strain EM1235 are all in a
phoN– background to improve the detection of the PhoA activity. Since these known and
unknown background mutations might have unanticipated effects on virulence, we
constructed glpQ knockouts in wild-type S. typhimurium strains, CR8500 and CR6600.
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Serum Killing Assays with ΔglpQ Strains
The serum killing assays that were performed with the glpQ deletion mutants
produced unanticipated results – when ΔglpQ strains were complimented with glpTQ on a
plasmid, survival in 90% serum was actually reduced rather than restored to wild-type levels.
Not only was survival in complemented strains reduced, but in most cases it was reduced to
levels slightly less than that of the actual ΔglpQ strains. The lack of complementation is
puzzling, especially since the same plasmid, pLX9610, was used in earlier experiments and
performed as expected. Previous studies in E.coli cloned the glpTQ operon into pBR322
without any reported expression issues (27, 28). One possible explanation is that somehow
the deletion of glpQ from the chromosome causes instability of the glpT transcript, resulting
in a lack of the glycerol 3-phosphate permease or a non-functional protein. In this scenario,
the ΔglpQ strain would not make sufficient GlpT while it would in the glpQ::TnphoA fusion.
For this to be consistent with the results, the complementing plasmid copy of glpT would
have to be nonfunctional in some way. It is also possible that deletion of glpQ from the
chromosome has an effect elsewhere in the genome that the complementation plasmid is not
accounting for and cannot correct. This might be a cis-acting effect on the divergent glpTQ
promoter, which appears to overlap the glpA promoter. However, this scenario does not seem
likely since other members of the glp regulon are not affected by the loss of glpQ function
(27). It would be interesting to test a different glpQ knockout strain that was generated during
the course of this study, which has an intron insertion in glpQ rather than a frank glpQ
deletion (not shown). Performing serum-killing assays with this glpQ intron insertion mutant
might answer the question of whether the current lack of complementation is a result of
chromosomal glpQ deletion. A glycerophosphodiesterase assay for the presence of the GlpQ
protein may also be informative. This assay could determine which strains were actually
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producing the protein and roughly how much of it they were producing; this may help in
trouble-shooting the problems with complementation.
Colony Phenotypes
During the course of experimentation, differences in colony morphology were
observed between wild-type Salmonella and some of the mutant strains generated in this
study. The normal colony morphology for the wild-type strains, EM876, and all the ΔglpQ
strains consists of medium-sized, round, convex, ivory-colored colonies as seen in Figure
11A.

A.

B.

Figure 11. Colony morphologies. (A) Normal opaque colony morphology. (B) Mixed
colony morphologies with both opaque and translucent colonies.
In contrast, all of the strains containing the complementation plasmid, pLX9610, had
two different colony phenotypes (Figure 11B). Overall, the colonies were smaller than
normal and irregularly shaped. Nearly half the colonies have a raised margin and are
somewhat translucent, while the other half are opaque and have a wrinkled surface. There are
also single colonies that appear to have both phenotypes. The only minor difference between
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the complemented strains was that EM1235 appeared to have a predominance of the
translucent colony phenotype over the opaque phenotype (approximately 80% vs. 20%).
Taking a single colony from the plate in Figure 11B and streaking for isolation on
fresh media produced the same mix of colony morphologies. This happened no matter which
phenotype the starting colony displayed, which suggests that all of the colonies with
alternative phenotypes encode the factor or factors that produce both morphologies. In
addition, EcoRI restriction analysis performed on plasmid DNA isolated from each colony
type confirmed the presence of pLX9610.
Interestingly, survivors of the serum-killing experiments showed no phenotypic
differences at all. All of the colonies showed the morphology as seen in Figure 11A. One
interpretation of this observation is that the failure of the glpQ complementing plasmid to
restore serum-resistance to ΔglpQ strains is due to the generation of an altered (translucent)
colony phenotype that is more serum-sensitive than the normal (opaque) colony morphotype.
The source of the colony dimorphism is likely to be pLX9610, since only strains
complemented with this plasmid show this trait. These differences in morphology are
consistent with changes in the protein constituents of membranes. There is evidence that
Protein II phase variants of Neisseria can switch between opaque and translucent colony
phenotypes (5). It is unknown, however, what physiologic difference or specific genetic
mechanism are causing these changes in the S. typhimurium colony appearance. The high
and consistent frequency of these morphological types is consistent with phase variation (7)
or, perhaps, a dysfunctional regulatory process. There is a report in E. coli of the
development of opaque and translucent colony morphologies as a result of overexpression of
a cloned protein (2). It is possible that cloning the glpTQ operon into a high copy vector
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raises gene expression to a toxic level. It may be worth cloning the glpTQ operon into
medium and low copy vectors to evaluate how well they can complement the deletion or
disruption of glpQ. Using a low copy vector would also reduce the likelihood of unwanted
homologous recombination with the chromosome. In any case, the effects could be
pleiotrophic and extend beyond the glpTQ and glpA operons.
This study has demonstrated for the first time a possible relationship between glpQ
and virulence in Salmonella typhimurium. Results from alkaline phosphatase assays strongly
suggest differential expression of glpQ at higher temperatures. This is consistent with the fact
that genes encoding virulence traits are often temperature-regulated (22). Results from serum
killing assays are less clear. However, there is a consistent decrease in serum resistance when
glpQ is deleted from the chromosome, which indicates that glpQ is likely promoting
increased survival in serum by an unknown mechanism. Previous work has shown that the
traT gene located on the virulence plasmid is also temperature-regulated and responsible for
serum-resistance (46). Interestingly, there is possible evidence in Shigella flexneri that
crosstalk between the virulence plasmid and the chromosome regulates virulence
determinants (47). The study found that upon curing out the virulence plasmid, genes of the
glp regulon, particularly glpQ, were upregulated. It is not known how the virulence plasmid
and chromosome work together to regulate virulence, but it is possible that housekeeping
genes like glpQ act as global regulators that support virulence functions (45). The idea of
housekeeping genes as “virulence life-style genes” (45) is becoming more prevalent as
researchers move toward a more holistic view of bacterial pathogenesis, in which regulatory
elements and genes involved in metabolism are coming to the forefront. This study adds to
the growing body of evidence that is redefining housekeeping and virulence genes.
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